MEI Pharma (NASDAQ:MEIP) Receives New Coverage from Analysts at StockNews.com
StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research report sent to investors on Saturday morning. The firm issued a buy rating on the stock. Other equities analysts have also issued reports about the stock. Brookline Capital Management lowered shares of MEI Pharma from a strong-buy rating to a […]
2 Oct 05:33 · The Markets Daily